P2RY6 | Pyrimidinergic receptor P2Y, G-protein coupled, 6 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PARP15 | Poly (ADP-ribose) polymerase family, member 15 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
PCDH17 | Protocadherin 17 | Predicted membrane proteins
| | | | | Tissue enhanced |
PCSK6 | Proprotein convertase subtilisin/kexin type 6 | Enzymes
| | | | | Tissue enhanced |
PDE6G | Phosphodiesterase 6G, cGMP-specific, rod, gamma | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
PF4V1 | Platelet factor 4 variant 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PITPNM3 | PITPNM family member 3 | Disease related genes
| | | | | Tissue enhanced |
PKD2L1 | Polycystic kidney disease 2-like 1 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
PRF1 | Perforin 1 (pore forming protein) | Cancer-related genes Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
PSTPIP2 | Proline-serine-threonine phosphatase interacting protein 2 | Cytoskeleton related proteins
| | | | | Tissue enhanced |
PTCRA | Pre T-cell antigen receptor alpha | Predicted membrane proteins
| | | | | Tissue enhanced |
PTGER1 | Prostaglandin E receptor 1 (subtype EP1), 42kDa | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
PTPRCAP | Protein tyrosine phosphatase, receptor type, C-associated protein | Predicted secreted proteins
| | | | | Tissue enhanced |
RENBP | Renin binding protein | Enzymes
| | | | | Tissue enhanced |
RGS18 | Regulator of G-protein signaling 18 | | | | | | Tissue enhanced |
RGS19 | Regulator of G-protein signaling 19 | | | | | | Tissue enhanced |
RP11-599B13.6 | Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enhanced |
S1PR4 | Sphingosine-1-phosphate receptor 4 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
SAP25 | Sin3A-associated protein, 25kDa | | | | | | Tissue enhanced |
SCIMP | SLP adaptor and CSK interacting membrane protein | Predicted membrane proteins
| | | | | Tissue enhanced |
SCN11A | Sodium channel, voltage-gated, type XI, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
SEMA3D | Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D | | | | | | Tissue enhanced |
SH2D1B | SH2 domain containing 1B | | | | | | Tissue enhanced |
SHANK3 | SH3 and multiple ankyrin repeat domains 3 | | | | | | Tissue enhanced |
SIGLEC12 | Sialic acid binding Ig-like lectin 12 (gene/pseudogene) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SIGLEC14 | Sialic acid binding Ig-like lectin 14 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SIGLEC5 | Sialic acid binding Ig-like lectin 5 | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
SIGLEC5 | | Predicted membrane proteins
| | | | | Tissue enhanced |
SIGLEC7 | Sialic acid binding Ig-like lectin 7 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SLC9A5 | Solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SNTG1 | Syntrophin, gamma 1 | Cytoskeleton related proteins Plasma proteins
| | | | | Tissue enhanced |
TAC1 | Tachykinin, precursor 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
TBX21 | T-box 21 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
TCHH | Trichohyalin | Cytoskeleton related proteins Plasma proteins
| | | | | Tissue enhanced |
TDGF1 | Teratocarcinoma-derived growth factor 1 | | | | | | Tissue enhanced |
TLX1NB | TLX1 neighbor | | | | | | Tissue enhanced |
TMC8 | Transmembrane channel-like 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
TMEM26 | Transmembrane protein 26 | Predicted membrane proteins
| | | | | Tissue enhanced |
TNFRSF13B | Tumor necrosis factor receptor superfamily, member 13B | CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
TTC24 | Tetratricopeptide repeat domain 24 | | | | | | Tissue enhanced |
TUBB1 | Tubulin, beta 1 class VI | Disease related genes FDA approved drug targets Plasma proteins
| | | | | Tissue enhanced |
UNC13A | Unc-13 homolog A (C. elegans) | | | | | | Tissue enhanced |
VCAM1 | Vascular cell adhesion molecule 1 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
VMO1 | Vitelline membrane outer layer 1 homolog (chicken) | Predicted secreted proteins
| | | | | Tissue enhanced |
WDR86 | WD repeat domain 86 | | | | | | Tissue enhanced |